ARTICLE | Company News
Dor's orBec delayed
June 30, 2006 11:50 PM UTC
DORB pushed back its timeline for submitting an NDA for orBec beclomethasone dipropionate to treat gastrointestinal graft-versus-host disease (GI GvHD) to July or August. The company had expected to s...